EluSys Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- EluSys Therapeutics's estimated annual revenue is currently $5.1M per year.
- EluSys Therapeutics's estimated revenue per employee is $213,125
- EluSys Therapeutics's total funding is $50.1M.
Employee Data
- EluSys Therapeutics has 24 Employees.
- EluSys Therapeutics grew their employee count by 4% last year.
EluSys Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Business Development | Reveal Email/Phone |
2 | Senior Director, Human Resources & Administration | Reveal Email/Phone |
3 | Director, Program Managment | Reveal Email/Phone |
4 | Director, CMC and Nonclinical Development | Reveal Email/Phone |
5 | Executive Director, Preclinical Development & Immunobiology | Reveal Email/Phone |
6 | Director, Regulatory Affairs | Reveal Email/Phone |
7 | sr. director quality assurance | Reveal Email/Phone |
8 | Director Clinical Operations | Reveal Email/Phone |
9 | Program Manager | Reveal Email/Phone |
10 | President & CEO | Reveal Email/Phone |
EluSys Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is EluSys Therapeutics?
EluSys is a biopharmaceutical company focused on the development of therapeutic monoclonal antibodies for the prevention and treatment of human diseases with unmet medical needs. EluSys' patented technology, the Heteropolymer, may offer a significant advance in the management and treatment of blood-borne viruses, bacteria, toxins and autoantibodies by enhancing the effectiveness of the body's natural defense mechanisms to remove such pathogens from the blood and destroy them. The company's cancer therapeutic is a single monoclonal antibody that shows early promise against a variety of cancers. Founded in 1998, EluSys is headquartered in Pine Brook, NJ.
keywords:N/A
$50.1M
Total Funding
24
Number of Employees
$5.1M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EluSys Therapeutics News
Heat Biologics (NightHawk Biosciences) Completes Acquisition of Elusys Therapeutics. Published: Apr 20, 2022. Elusys becomes wholly-owned biodefense...
Heat Biologics ('NightHawk Biosciences') Completes Acquisition of Elusys Therapeutics · DURHAM, N.C. - Heat Biologics, Inc. · U.S. and · Canada ,...
Expanded efforts by biodefense Elusys Therapeutics to support ... when alternative therapies are not available or are not appropriate.
Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media UPDATED at 5:45am on 9/27/07 GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new ...
Other Companies in Parsippany
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.4M | 24 | -8% | N/A |
#2 | $2.4M | 24 | 0% | $43.2M |
#3 | $4.7M | 25 | 9% | N/A |
#4 | $1.8M | 26 | -4% | N/A |
#5 | $2.7M | 27 | 17% | N/A |